- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00125866
The Effect of Cocoa Flavonoids on Blood Pressure
May 27, 2015 updated by: Imperial College London
The Effect of Cocoa Polyphenols on Various Cardiovascular Measurements Including Blood Pressure
The purpose of this study is to compare the effects on blood pressure of a daily intake of a flavonoid-rich cocoa drink with that of the same drink from which the flavonoids have been largely extracted.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Flavonoids are natural substances found in fruits and vegetables, tea and red wine.
The investigators know that people who eat a diet rich in these foods are less likely to have heart disease.
This, in part, may be due to the blood pressure lowering effect of flavonoids.
Cocoa beans are a rich natural source of flavonoids.
Unfortunately when cocoa is made into chocolate most of the flavonoids are destroyed.
The aim of this study is to find out the effect of cocoa flavonoids on blood pressure after 12 weeks of daily consumption of a specially prepared chocolate drink that is rich in flavonoids.
Study Type
Interventional
Enrollment
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
London
-
Paddington, London, United Kingdom, W2 1PG
- Imperial College London
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males or females of any age.
- Diagnosis of hypertension and on antihypertensive treatment.
- Stable blood pressure that has reached the British Hypertension Society (BHS) audit standard (<150/90mmHg).
Exclusion Criteria:
- Participation in another clinical trial.
- Any reason to suspect that the patient will not comply with drinking a chocolate beverage every day for the trial duration.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Difference in mean 24 hour ambulatory blood pressure
|
Secondary Outcome Measures
Outcome Measure |
---|
Difference in cholesterol
|
Difference in glucose
|
Difference in insulin
|
Difference in echocardiogram
|
Difference in pulse wave velocity
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2005
Study Completion (ACTUAL)
January 1, 2006
Study Registration Dates
First Submitted
July 29, 2005
First Submitted That Met QC Criteria
July 29, 2005
First Posted (ESTIMATE)
August 2, 2005
Study Record Updates
Last Update Posted (ESTIMATE)
May 28, 2015
Last Update Submitted That Met QC Criteria
May 27, 2015
Last Verified
April 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NPSW01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Flavonoid rich or flavonoid depleted chocolate drink
-
Laval UniversityCompleted
-
University of ReadingUnknown
-
University of ReadingWild Blueberry Association of North America (WBANA)RecruitingExecutive Function | Mood | AffectUnited Kingdom
-
University of California, San DiegoThe Hershey CompanyCompletedHeart Failure | Type 2 DiabetesUnited States
-
University of ReadingCompletedHealthy | Parents | Mood | Mothers | FathersUnited Kingdom
-
University of ReadingRecruiting
-
National Center for Complementary and Integrative...CompletedHypertensionUnited States
-
Shahid Beheshti UniversityShahid Beheshti University of Medical SciencesRecruiting
-
Neuromed IRCCSTerminatedCoronary Heart DiseaseItaly
-
Neuromed IRCCSCompletedToxicity Due to RadiotherapyItaly